Private equity company Post Capital Partners has announced the promotion of vice president Christopher Cheang to the position of director and head of business development.
In his new role, Cheang will foster relationships with the broader deal community to generate investment opportunities for the firm, the company said in a statement.
In his previous position, Cheang was instrumental in the success of the recent recapitalization of Invo HealthCare Associates by the Wicks Group of Companies, the statement continued. Prior to joining Post Capital in 2009, Cheang worked in Shanghai for Cabot China Limited, a joint venture of specialty chemicals company Cabot Corporation and beforehand was an investment banker with Adams Harkness.
“As head of business development, Chris will also be a key player in the implementation of Post Capital’s ‘Executive-First’ investment strategy,” said Michael Pfeffer, co-founder and managing director, in the statement. “We believe the availability of high quality senior management is the primary driver of a company’s success.”
Founded in 2004 and based in New York, Post Capital Partners makes both minority growth and control investments in businesses with repeat or recurring revenue models. The firm employs an “Executive-First” deal sourcing and investment strategy in which it first identifies and partners with talented senior operating executives, and then works proactively with those individuals to identify investments. The company is currently investing out of its second committed capital fund.